Potential prospects for use in pathology and treatment include elevated levels of vascular cell adhesion molecule 1 (VCAM-1) and neprilysin in patients with baseline diabetic nephropathy and diabetic nephropathy-treated patients with persisting albuminuria, respectively [106]. Here, MME is linked to diabetic kidney disease.